Zobrazeno 1 - 10
of 125
pro vyhledávání: '"Kirk M Chan-Tack"'
Publikováno v:
Infection Control & Hospital Epidemiology. 41:489-491
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1208669d592ce5e7b57abc3870b583fe
https://doi.org/10.1017/ice.2020.16
https://doi.org/10.1017/ice.2020.16
Autor:
Kimberly A Struble, Thamban Valappil, Dionne Price, Poonam Mishra, Kirk M Chan-Tack, Jeffrey S. Murray, Debra Birnkrant, Karen Qi, Sarah Connelly
Publikováno v:
Journal of Virus Eradication
Journal of Virus Eradication, Vol 5, Iss 3, Pp 138-144 (2019)
Journal of Virus Eradication, Vol 5, Iss 3, Pp 138-144 (2019)
Objectives Under representation of black subjects in trials of hepatitis C virus (HCV) direct-acting antivirals (DAAs) complicates assessment of differential outcomes for black individuals vs non-black individuals. HCV trials submitted to the Food an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e2732818baf9fe70e61d690a3e22b22
http://europepmc.org/articles/PMC6816110
http://europepmc.org/articles/PMC6816110
Publikováno v:
The New England journal of medicine. 383(27)
FDA Approval of Remdesivir On October 22, 2020, on the basis of the results of three phase 3 clinical trials, the FDA approved remdesivir for use in adults and pediatric patients (12 years of age o...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bac22cbbf2ff50f6a8665f9ea2de207
https://pubmed.ncbi.nlm.nih.gov/33264539
https://pubmed.ncbi.nlm.nih.gov/33264539
Autor:
Patrick R. Harrington, Kimberly A Struble, Kirk M Chan-Tack, Jeffrey S. Murray, Lisa K. Naeger, Sarita D. Boyd, Debra Birnkrant, Takashi E. Komatsu
Publikováno v:
Journal of Viral Hepatitis. 25:969-975
Multiple direct-acting antiviral (DAA)-based regimens are now available for all hepatitis C virus (HCV) genotypes (GTs). Because HCV GT 4, 5 and 6 are less common in the United States (US) and worldwide, relatively small numbers of participants with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a285cd17f963fd697743949374b6272
https://doi.org/10.1111/jvh.12896
https://doi.org/10.1111/jvh.12896
Autor:
Kimberly A Struble, Su-Young Choi, David McMillan, Timothy J Bensman, Eric F. Donaldson, Hanan Ghantous, Mark Seaton, Thamban Valappil, Laine Myers, Julian J. O'Rear, Debra Birnkrant, Patrick R. Harrington, Yu Cao, Kirk M Chan-Tack
Publikováno v:
Antiviral Research. 195:105182
The development and approval of brincidofovir for the treatment of smallpox, a disease that was eradicated from the world over 40 years ago, has resulted in the second antiviral approved via the Medical Countermeasure Initiative (MCMi) to combat this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bd6950ca96bf936746a2eea95ee509c
https://doi.org/10.1016/j.antiviral.2021.105182
https://doi.org/10.1016/j.antiviral.2021.105182
Publikováno v:
The Journal of Clinical Pharmacology. 57:S136-S142
In this review of individual patient expanded-access requests to the Center for Drug Evaluation and Research for the period Fiscal Year 2010 to Fiscal Year 2014, we evaluated the number of applications received and the number allowed to proceed. We a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7126886a04cbb7a920238257a4f03c80
https://doi.org/10.1002/jcph.960
https://doi.org/10.1002/jcph.960
Publikováno v:
Hepatology (Baltimore, Md.). 67(2)
On July 18, 2017, the U.S. Food and Drug Administration (FDA) approved sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) (Vosevi) fixed-dose combination (FDC), an interferon-free, complete regimen for adult patients with chronic hepatitis C virus (HC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::530f6b217708f37c8050e65859b5e424
https://pubmed.ncbi.nlm.nih.gov/29059462
https://pubmed.ncbi.nlm.nih.gov/29059462
Autor:
Susan Zhou, Karen Qi, Min Min, Kimberly A Struble, Jeffrey Murray, Kirk M. Chan-Tack, Guoxing Greg Soon, Rafia Bhore, Thomas Hammerstrom, Debra Birnkrant
Publikováno v:
AIDS Patient Care and STDs. 26:444-453
Women are often underrepresented in randomized clinical trials (RCT) of HIV-1 drugs. As a result, determining whether women have different virologic outcomes compared to men is not always possible because the gender-related analyses usually lack stat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fdbdc96f8fd83632ff602412da1c624
https://doi.org/10.1089/apc.2011.0278
https://doi.org/10.1089/apc.2011.0278
Publikováno v:
Postgraduate Medicine. 121:107-113
Cryptococcosis continues to have a high mortality rate in human immunodeficiency virus (HIV)-positive patients despite advances made in antifungal treatment, intracranial pressure management, and antiretroviral therapy. This retrospective chart revie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf693e204bcf7912d0344a6d13aafe11
https://doi.org/10.3810/pgm.2009.03.1983
https://doi.org/10.3810/pgm.2009.03.1983
Autor:
Jennifer L. DiGiacinto, Kimberly A Struble, Kirk M Chan-Tack, Kellie S. Reynolds, Sarah M. Robertson
Publikováno v:
The Journal of Clinical Pharmacology. 48:518-523
One of the numerous regulatory functions of the Food and Drug Administration (FDA) is the evaluation of drug-drug interactions and the determination of appropriate dose adjustments, if necessary, to ensure the safe and effective use of medications. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b524d7c5be9b151f78399315a58858c6
https://doi.org/10.1177/0091270008315308
https://doi.org/10.1177/0091270008315308